Medicare Enrolled
Anna Belcheva, M. D.
Hematology & Oncology · Houston, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Belcheva from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Belcheva?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Belcheva
Anna Belcheva is a hematology & oncology specialist in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Belcheva performed 63,994 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Belcheva received a total of $8,014 from 77 pharmaceutical and/or device companies across 397 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Belcheva is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 15% volume in TX
$8,014 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗63,994
Medicare services
Top 15% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
23,460 | $0 | $5 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
9,800 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 9,400 | $43 | $137 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
8,040 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
4,950 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 4,080 | $18 | $66 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,041 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
579 | $8 | $36 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
534 | $96 | $368 |
| Anti-nausea injection (Aloxi/palonosetron) | 430 | $1 | $114 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
168 | $103 | $707 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
162 | $8 | $20 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
161 | $23 | $157 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
150 | $11 | $96 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
133 | $2 | $300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
127 | $62 | $250 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
120 | $51 | $313 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
102 | $12 | $108 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
84 | $10 | $64 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
65 | $50 | $344 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
57 | $1 | $7 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
36 | $35 | $143 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
33 | $22 | $161 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $112 | $565 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
31 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
31 | $6 | $34 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
31 | $5 | $26 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
29 | $25 | $145 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
29 | $1 | $8 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
29 | $2 | $19 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
26 | $19 | $114 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
22 | $2 | $16 |
| New patient office visit, complex (60-74 min) | 22 | $164 | $709 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
37.5% high complexity
59.8% medium
2.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,014
Total received (2018-2024)
Avg $1,145/year across 7 years
Top 35% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
397
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,017
2023
$2,253
2022
$1,142
2021
$290
2020
$120
2019
$98
2018
$94
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$357
Janssen Biotech, Inc.
$344
SpringWorks Therapeutics, Inc.
$268
Novartis Pharmaceuticals Corporation
$255
Tempus AI, Inc
$224
PFIZER INC.
$206
Celgene Corporation
$156
Daiichi Sankyo Inc.
$142
Eisai Inc.
$133
Astellas Pharma US Inc
$124
SOBI, INC
$110
Takeda Pharmaceuticals U.S.A., Inc.
$106
GENZYME CORPORATION
$100
JAZZ PHARMACEUTICALS INC.
$95
Gilead Sciences, Inc.
$84
Boston Scientific Corporation
$82
E.R. Squibb & Sons, L.L.C.
$76
BeiGene USA, Inc.
$76
EMD Serono, Inc.
$66
Stemline Therapeutics Inc.
$66
Regeneron Healthcare Solutions, Inc.
$63
ABBVIE INC.
$62
Merck Sharp & Dohme LLC
$60
TerSera Therapeutics LLC
$60
PUMA BIOTECHNOLOGY, INC.
$59
Adaptive Biotechnologies Corporation
$57
Fennec Pharmaceuticals, Inc.
$42
ARRAY BIOPHARMA INC
$42
Myriad Genetic Laboratories, Inc.
$37
Incyte Corporation
$36
Aveo Pharmaceuticals, Inc.
$36
Sirtex Medical Inc
$34
Deciphera Pharmaceuticals Inc.
$30
Lilly USA, LLC
$30
Genentech USA, Inc.
$29
Rigel Pharmaceuticals, Inc.
$27
Bayer Healthcare Pharmaceuticals Inc.
$25
Pharmacosmos Therapeutics Inc.
$23
Mirati Therapeutics, Inc.
$22
Dendreon Pharmaceuticals LLC
$21
Ipsen Biopharmaceuticals, Inc
$20
GlaxoSmithKline, LLC.
$19
Pharming Healthcare, Inc.
$18
Karyopharm Therapeutics Inc.
$17
ADC Therapeutics America, Inc.
$16
TAIHO ONCOLOGY, INC.
$16
SHIELD THERAPEUTICS INC
$15
Spectrum Pharmaceuticals Inc.
$15
Tactile Systems Technology Inc
$14
Top 3 companies account for 24.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$644
AstraZeneca Pharmaceuticals LP
$633
PFIZER INC.
$383
Novartis Pharmaceuticals Corporation
$363
Celgene Corporation
$321
Amgen Inc.
$311
GENZYME CORPORATION
$270
SpringWorks Therapeutics, Inc.
$268
Daiichi Sankyo Inc.
$229
Astellas Pharma US Inc
$227
Tempus AI, Inc
$224
Eisai Inc.
$222
Merck Sharp & Dohme LLC
$173
Bayer HealthCare Pharmaceuticals Inc.
$145
TerSera Therapeutics LLC
$139
Takeda Pharmaceuticals U.S.A., Inc.
$136
E.R. Squibb & Sons, L.L.C.
$136
SOBI, INC
$125
EMD Serono, Inc.
$123
Lilly USA, LLC
$117
Tactile Systems Technology Inc
$116
Gilead Sciences, Inc.
$115
JAZZ PHARMACEUTICALS INC.
$112
Boston Scientific Corporation
$108
Seagen Inc.
$101
Pharmacosmos Therapeutics Inc.
$99
Adaptive Biotechnologies Corporation
$93
Regeneron Healthcare Solutions, Inc.
$93
ABBVIE INC.
$93
Myriad Genetic Laboratories, Inc.
$84
Alexion Pharmaceuticals, Inc.
$83
Stemline Therapeutics Inc.
$83
TAIHO ONCOLOGY, INC.
$76
BeiGene USA, Inc.
$76
MorphoSys, US Inc.
$73
GlaxoSmithKline, LLC.
$72
Sirtex Medical Inc
$69
AVEO Pharmaceuticals, Inc.
$65
Janssen Pharmaceuticals, Inc
$64
Rigel Pharmaceuticals, Inc.
$61
Fennec Pharmaceuticals, Inc.
$60
PUMA BIOTECHNOLOGY, INC.
$59
Genentech USA, Inc.
$52
Puma Biotechnology, Inc.
$50
Bayer Healthcare Pharmaceuticals Inc.
$50
Incyte Corporation
$50
ARRAY BIOPHARMA INC
$42
Mylan Institutional Inc.
$41
EISAI INC.
$39
Verity Pharmaceuticals Inc.
$37
Aveo Pharmaceuticals, Inc.
$36
ADC Therapeutics America, Inc.
$34
AbbVie Inc.
$34
Ipsen Biopharmaceuticals, Inc
$33
Deciphera Pharmaceuticals Inc.
$30
Clovis Oncology, Inc.
$28
CTI BioPharma Corp.
$24
Inari Medical, Inc.
$23
Apellis Pharmaceuticals, Inc.
$23
Exelixis Inc.
$22
Mirati Therapeutics, Inc.
$22
Taiho Oncology, Inc.
$22
Pharmacyclics LLC, an AbbVie Company
$22
Dendreon Pharmaceuticals LLC
$21
Merck Sharp & Dohme Corporation
$21
Sumitomo Pharma America, Inc.
$21
Immunocore Limited
$20
Lexicon Pharmaceuticals, Inc.
$19
TESARO, Inc.
$19
Sun Pharmaceutical Industries Inc.
$19
Pharming Healthcare, Inc.
$18
Kyowa Kirin, Inc.
$17
Karyopharm Therapeutics Inc.
$17
SHIELD THERAPEUTICS INC
$15
Spectrum Pharmaceuticals Inc.
$15
Amneal Pharmaceuticals LLC
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 20.7% of all-time payments
Associated products mentioned in payments ›
ABECMA · ACCRUFER · ADCETRIS · ALUNBRIG · AVASTIN · Alecensa · Aliqopa · BAVENCIO · BOSULIF · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · DARZALEX · Doptelet · ELIQUIS · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · FLOWTRIEVER CATHETER · FOTIVDA · FRUZAQLA · Flexitouch Plus · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Itovebi · JAKAFI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · MVASI · MYRISK · NINLARO · Nerlynx · Nplate · Nubeqa · OGIVRI · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · ORIAHNN · OXBRYTA · Odomzo · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROVENGE · Padcev · Pedmark · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · ROLVEDON · RUCONEST · RYBREVANT · Rezlidhia · Rubraca · S · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SYNAGIS · Stivarga · TABRECTA · TAFINLAR · TAGRISSO · TheraSphere Y90 Glass Microspheres 10 GBq · Trelstar · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · Vitrakvi · Vonjo · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · XYNTHA · Xermelo · Xospata · Xtandi · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
203
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST WILLOWBROOK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Belcheva is a mixed practice specialist, with above-average Medicare volume (top 15% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Belcheva experienced with iron infusion (feraheme)?
Based on Medicare claims data, Belcheva performed 23,460 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Belcheva receive payments from pharmaceutical companies?
Yes. Belcheva received a total of $8,014 from 77 companies across 397 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Belcheva's costs compare to other hematology & oncology specialists in Houston?
Belcheva's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Belcheva) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Houston
Browse hematology & oncology specialists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology